Hydroxychloroquine combination risky for cancer patients with COVID-19: Study

US researchers found that cancer patients with COVID-19 who were being administered with hydroxychloroquine with the antibiotic azithromycin drug combination to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone.

from Zee News :World https://ift.tt/2XdHMjr
Share:

No comments:

Post a Comment

Search This Blog

  • ()
  • ()
Show more
Powered by Blogger.

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.